FDA Denial Of Mucinex Petition Stops Reckitt's Bid To Delay Generics
By
The Tan Sheet / “The Tan Sheet” Jan. 18, 2010, Vol. 18, No. 003
Regulatory / Word Count: 594 / Article # 05180030002
Executive Summary
FDA stymies Reckitt Benckiser's attempt to delay private label competition for Mucinex OTC cough products by rejecting the firm's request to redefine bioequivalence standards for guaifenesin generics
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.